162 related articles for article (PubMed ID: 15701268)
1. High-dose-rate brachytherapy in combination with stenting offers a rapid and statistically significant improvement in quality of life for patients with endobronchial recurrence.
Allison R; Sibata C; Sarma K; Childs CJ; Downie GH
Cancer J; 2004; 10(6):368-73. PubMed ID: 15701268
[TBL] [Abstract][Full Text] [Related]
2. Impact of Silicone Stent Placement in Symptomatic Airway Obstruction due to Non-Small Cell Lung Cancer - A French Multicenter Randomized Controlled Study: The SPOC Trial.
Dutau H; Di Palma F; Thibout Y; Febvre M; Cellerin L; Naudin F; Hermant C; Vallerand H; Lachkar S; Fournier C; Laroumagne S; Quiot JJ; Vergnon JM;
Respiration; 2020; 99(4):344-352. PubMed ID: 32213777
[TBL] [Abstract][Full Text] [Related]
3. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
4. Bronchoscopic palliation of primary lung cancer: single or multimodality therapy?
Santos RS; Raftopoulos Y; Keenan RJ; Halal A; Maley RH; Landreneau RJ
Surg Endosc; 2004 Jun; 18(6):931-6. PubMed ID: 15108108
[TBL] [Abstract][Full Text] [Related]
5. A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience.
Goldberg M; Timotin E; Farrell T; Puksa S; Donde B; Sur R
Brachytherapy; 2015; 14(5):655-61. PubMed ID: 25983031
[TBL] [Abstract][Full Text] [Related]
6. Endobronchial radiation therapy for obstructing malignancies: ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients.
Macha HN; Wahlers B; Reichle C; von Zwehl D
Lung; 1995; 173(5):271-80. PubMed ID: 7564485
[TBL] [Abstract][Full Text] [Related]
7. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
[TBL] [Abstract][Full Text] [Related]
9. Salvage treatment with sole high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in non-small-cell lung cancer patients: a 20-year experience.
Soror T; Kovács G; Fürschke V; Ismail M; Badakhshi H
Brachytherapy; 2019; 18(5):727-732. PubMed ID: 31227399
[TBL] [Abstract][Full Text] [Related]
10. Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC).
Weinberg BD; Allison RR; Sibata C; Parent T; Downie G
Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):50-8. PubMed ID: 20230994
[TBL] [Abstract][Full Text] [Related]
11. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
12. [High-dose endobronchial brachytherapy in malignant tumors of the lung].
Escobar Sacristán J; de Granda Orive JI; Gutiérrez Jiménez T; Martínez Albiach JM; Fuentes Ramos M; Herrera de la Rosa A
Arch Bronconeumol; 1997 Jun; 33(6):278-83. PubMed ID: 9289322
[TBL] [Abstract][Full Text] [Related]
13. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
14. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
[TBL] [Abstract][Full Text] [Related]
15. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
[TBL] [Abstract][Full Text] [Related]
16. High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.
Hernandez P; Gursahaney A; Roman T; Schwartzman K; Donath D; Cosio MG; Levy RD
Thorax; 1996 Apr; 51(4):354-8. PubMed ID: 8733484
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate (HDR) brachytherapy for the treatment of benign obstructive endobronchial granulation tissue.
Madu CN; Machuzak MS; Sterman DH; Musani A; Ahya V; McDonough J; Metz JM
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1450-6. PubMed ID: 16997502
[TBL] [Abstract][Full Text] [Related]
18. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study.
Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M
Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886
[TBL] [Abstract][Full Text] [Related]
19. High dose rate endobronchial brachytherapy (HDR-EB) in recurrent benign complex tracheobronchial stenosis: experience in two cases.
Tscheikuna J; Disayabutr S; Kakanaporn C; Tuntipumi-Amorn L; Chansilpa Y
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S252-6. PubMed ID: 23590050
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue.
Tendulkar RD; Fleming PA; Reddy CA; Gildea TR; Machuzak M; Mehta AC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):701-6. PubMed ID: 17904764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
